Is Capmatinib available in China? Is it easy to buy?

Introduction: Capmatinib, trade name Tabrecta, is an anti-cancer drug used to treat metastatic non-small cell lung cancer. Tumor mutations in this type of cancer lead to skipping of exon 14 of the MET gene, which encodes the membrane receptor HGFR. Capmatinib is an oral, highly selective c-Met kinase inhibitor that is highly selective for MET targets. It can effectively inhibit the proliferation and migration of c-Met-dependent tumor cells and induce apoptosis to achieve anti-tumor activity.

Capmatinib’s listing in China

As of June 6, 2024, has not yet been approved for marketing in the mainland, but capmatinib has been launched in Taiwan, China on February 26, 2021, and has been included in the catalog of urgently needed imported drugs and medical devices from Hong Kong and Macao for clinical use in the Guangdong-Hong Kong-Macao Greater Bay Area, and has been approved for use in Modern Hospital Guangzhou. Capmatinib has been approved by the US FDA for the treatment of non-small cell lung cancer (NSCLC) patients carrying MET exon 14 skipping mutations, and has been marketed in the United States, Japan, the European Union and other countries and regions.

How to purchase capmatinib

1. Hospital: You can purchase capmatinib in countries or regions where capmatinib is already on the market. After visiting the hospital, the doctor will issue a prescription and you can purchase capmatinib directly in the hospital pharmacy.

2. Pharmacies: Capmatinib is usually available in pharmacies in countries or regions where capmatinib is already on the market. You can go to large pharmacies to purchase it.

3. Medical service institutions: Patients in mainland China can purchase capmatinib through regular medical service institutions. They can buy the version listed in Hong Kong, China, or the generic version.

The price of capmatinib

1. The specification of capmatinib produced by Lucius Pharmaceuticals in Laos is 200mgx60 tablets/box, and the price of a box is approximately between 2650$-3300$.

2. The specification of capmatinib produced by Bangladesh Everest is 200mg*56 capsules/box, and the price of a box is about 3600$-4000$.

The above prices are for reference only, and the actual price shall prevail.